Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    September 2024
  1. RERKPICHAISUTH V, Lau RP, Meyerson C, Fishbein GA, et al
    The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma.
    Hum Pathol. 2024;151:105627.
    PubMed     Abstract available


    August 2024
  2. KAMINUMA Y, Nakai T, Aokage K, Taki T, et al
    Prognostic significance of micronest in cancer stroma in resected lung squamous cell carcinoma.
    Hum Pathol. 2024;150:20-28.
    PubMed     Abstract available


    July 2024
  3. JAN YH, Lu CT, Lam AK
    Comparison of genomic profiling of patient-matched primary colorectal and surgical resected distant metastatic (stage IV) colorectal carcinoma for drug actionability.
    Hum Pathol. 2024;149:21-28.
    PubMed     Abstract available


    June 2024
  4. DONG K, Zhu Y, Liu X, Sun W, et al
    Feasibility of Two-Step Approach for Screening NTRK Fusion in Two Major Subtypes of Non-Small Cell Lung Cancer Within a Large Cohort.
    Hum Pathol. 2024 Jun 10:S0046-8177(24)00104.
    PubMed     Abstract available


    May 2024
  5. SUN W, Qu L, Wu J, Liu X, et al
    "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
    Hum Pathol. 2024 May 21:S0046-8177(24)00093.
    PubMed     Abstract available


    April 2024
  6. NASO JR, Wang D, Romero AO, Leclair T, et al
    Pulmonary gangliocytic paraganglioma: An under-recognized mimic of carcinoid tumor.
    Hum Pathol. 2024;146:23-27.
    PubMed     Abstract available


    February 2024
  7. IVANOVA M, Frascarelli C, Cerbelli B, Pignataro MG, et al
    PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
    Hum Pathol. 2024;144:22-27.
    PubMed     Abstract available


    December 2023
  8. WANG H, Yan L, Zhu Y, Sun W, et al
    Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
    Hum Pathol. 2023;142:81-89.
    PubMed     Abstract available


    November 2023
  9. VAN PEL DM, Cheung S, Ionescu DN, Churg A, et al
    Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
    Hum Pathol. 2023;141:64-68.
    PubMed     Abstract available


    August 2023
  10. ZHU Y, Li S, Wang H, Chi K, et al
    Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung cancer.
    Hum Pathol. 2023 Aug 14:S0046-8177(23)00166.
    PubMed     Abstract available


    May 2023
  11. WANG M, Chen PP, Cai G
    GATA3 expression in primary lung carcinomas: correlation with histopathologic features and TTF-1, napsin A, and p40 expression.
    Hum Pathol. 2023;135:93-98.
    PubMed     Abstract available


    October 2022
  12. BOSSE Y, Gagne A, Althakfi W, Orain M, et al
    Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
    Hum Pathol. 2022;128:56-68.
    PubMed     Abstract available


  13. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
    A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Hum Pathol. 2022;128:31-47.
    PubMed     Abstract available


    August 2022
  14. CHANG WC, Yeh YC, Ho HL, Chou TY, et al
    Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
    Hum Pathol. 2022;126:9-18.
    PubMed     Abstract available


    May 2022
  15. AMBROSINI-SPALTRO A, Farnedi A, Calistri D, Rengucci C, et al
    The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies' integration.
    Hum Pathol. 2022;123:20-30.
    PubMed     Abstract available


    April 2022
  16. LIU L, Wei J, Teng F, Zhu Y, et al
    Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84-92].
    Hum Pathol. 2022;125:1.
    PubMed    


  17. ISHIKAWA R, Kadota K, Ikeda T, Yoshida C, et al
    Prognostic Impact of Tumor-infiltrating Lymphocytes and Neutrophils in Resected Non-small Cell Lung Carcinoma.
    Hum Pathol. 2022 Apr 25. pii: S0046-8177(22)00102.
    PubMed     Abstract available


    March 2022
  18. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    PubMed     Abstract available


    February 2022
  19. MOAYED-ALAEI L, Vargas AC, Adybeik D, Maclean F, et al
    Analyzing the morphological spectrum of epithelioid fibrous histiocytoma and the immunohistochemical performance of the ALK D5F3 and ALK1 clones.
    Hum Pathol. 2022;120:46-56.
    PubMed     Abstract available


    December 2021
  20. LAWLOR RT, Mafficini A, Sciammarella C, Cantu C, et al
    Genomic characterization of hepatoid tumors: context matters.
    Hum Pathol. 2021;118:30-41.
    PubMed     Abstract available


    September 2021
  21. WANG M, Abi-Raad R, Baldassarri R, Adeniran AJ, et al
    Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Hum Pathol. 2021;115:104-111.
    PubMed     Abstract available


  22. TONNESEN E, Lade-Keller J, Stougaard M
    Frequently used quantitative polymerase chain reaction-based methods overlook potential clinically relevant genetic alterations in epidermal growth factor receptor compared with next-generation sequencing: a retrospective clinical comparison of 1839 l
    Hum Pathol. 2021;115:67-75.
    PubMed     Abstract available


  23. CHEN M, Yang J, Lv L, Li Y, et al
    Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.
    Hum Pathol. 2021;115:56-66.
    PubMed     Abstract available


    August 2021
  24. WANG B, Chen R, Wang C, Guo J, et al
    Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
    Hum Pathol. 2021;114:90-98.
    PubMed     Abstract available


    March 2021
  25. ITAMI H, Fujii T, Nakai T, Takeda M, et al
    TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared to malignant mesothelioma.
    Hum Pathol. 2021 Mar 2. pii: S0046-8177(21)00032.
    PubMed     Abstract available


    February 2021
  26. YANAGAWA N, Shiono S, Endo M, Ogata SY, et al
    Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Hum Pathol. 2021;108:12-21.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.